Treatment of Covid-19 With a Herbal Compound, Xagrotin

Summary

This is an interventional, multi-center, randomized study. Adults with confirmed covid-19 disease not more than 10 days before enrollment date were recruited (n=361). Patients in same condition who had treated with standard of care were randomly assigned to the control group (n=178). The investigators analyzed the effect of a herbal compound, Xagrotin, and also investigated impact of different characteristics for instance gender, age, duration of disease, smoking habits and concomitant diseases on the outcome.

Timeline

Start

2020-07-01

Primary completion

2020-12-07

Completion

2021-02-08

Drugs

Indications